DrugPatentWatch Database Preview
MAGNESIUM SULFATE IN PLASTIC CONTAINER Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Magnesium Sulfate In Plastic Container patents expire, and what generic alternatives are available?
Magnesium Sulfate In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Mylan Labs Ltd. and is included in five NDAs.
The generic ingredient in MAGNESIUM SULFATE IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Magnesium Sulfate In Plastic Container
A generic version of MAGNESIUM SULFATE IN PLASTIC CONTAINER was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
Summary for MAGNESIUM SULFATE IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 97 |
| Clinical Trials: | 193 |
| Patent Applications: | 1,386 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MAGNESIUM SULFATE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wright State University | Phase 4 |
| Kasr El Aini Hospital | N/A |
| Dalia Saad Abd-El Kader | Phase 4 |
See all MAGNESIUM SULFATE IN PLASTIC CONTAINER clinical trials
Pharmacology for MAGNESIUM SULFATE IN PLASTIC CONTAINER
US Patents and Regulatory Information for MAGNESIUM SULFATE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 211966-001 | Jun 1, 2020 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-005 | Dec 6, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Fresenius Kabi Usa | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 206485-005 | Mar 15, 2016 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Fresenius Kabi Usa | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 206485-003 | Mar 15, 2016 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-004 | Jan 18, 1995 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
